Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1h-imidazol-2-yl)methyl)benzamide
2. In 1130
3. In-1130
4. In1130
1. In-1130
2. 868612-83-3
3. In 1130
4. In1130
5. Chembl492634
6. Kw4o83pq97
7. Benzamide, 3-((5-(6-methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1h-imidazol-2-yl)methyl)-
8. 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1h-imidazol-2-yl) Methyl)benzamide
9. 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1h-imidazol-2-yl)methyl)benzamide
10. Unii-kw4o83pq97
11. Schembl139815
12. Schembl22170124
13. Bdbm50252542
14. Zinc13985930
15. Akos032962854
16. Ncgc00386726-01
17. Ncgc00386726-02
18. Hy-18758
19. Cs-0014265
20. E98928
21. Q27282469
22. 3-[[5-(6-methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1h-imidazol-2-yl]methyl]benzamide
23. 3-[[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]methyl]benzamide
24. 940003-47-4
Molecular Weight | 420.5 g/mol |
---|---|
Molecular Formula | C25H20N6O |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 420.16985928 g/mol |
Monoisotopic Mass | 420.16985928 g/mol |
Topological Polar Surface Area | 110 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 646 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl, including repackagers and relabelers. The FDA regulates Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl supplier is an individual or a company that provides Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl active pharmaceutical ingredient (API) or Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl finished formulations upon request. The Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl suppliers may include Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl API manufacturers, exporters, distributors and traders.
click here to find a list of Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl DMF (Drug Master File) is a document detailing the whole manufacturing process of Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl active pharmaceutical ingredient (API) in detail. Different forms of Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl DMFs exist exist since differing nations have different regulations, such as Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl DMF submitted to regulatory agencies in the US is known as a USDMF. Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl USDMF includes data on Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl suppliers with USDMF on PharmaCompass.
Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl GMP manufacturer or Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl GMP API supplier for your needs.
A Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl CoA (Certificate of Analysis) is a formal document that attests to Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl's compliance with Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl specifications and serves as a tool for batch-level quality control.
Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl CoA mostly includes findings from lab analyses of a specific batch. For each Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl may be tested according to a variety of international standards, such as European Pharmacopoeia (Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl EP), Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl USP).
LOOKING FOR A SUPPLIER?